| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/18/2005 | CA2554591A1 Photodynamic therapy for the treatment of acne |
| 08/18/2005 | CA2554572A1 Montelukast free acid polymorphs |
| 08/18/2005 | CA2554362A1 Treatment of neurodegenerative diseases by the use of atp7a inhibitors |
| 08/18/2005 | CA2554329A1 Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity |
| 08/18/2005 | CA2554260A1 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole |
| 08/18/2005 | CA2554217A1 Diaza- or thiazadione derivatives with neuroprotective activity |
| 08/18/2005 | CA2554140A1 Methods and compositions for treating cancer |
| 08/18/2005 | CA2554120A1 N-benzyl-3,4-dihydroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integras inhibitors |
| 08/18/2005 | CA2554091A1 Prodrug comprising 5-aminosalicylate glycoside |
| 08/18/2005 | CA2554082A1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 08/18/2005 | CA2554050A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| 08/18/2005 | CA2554030A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders |
| 08/18/2005 | CA2553970A1 Spiro-benzodioxoles and their use as cb1 antagonists |
| 08/18/2005 | CA2553928A1 Susceptibility gene for myocardial infarction, stroke, and paod; methods of treatment |
| 08/18/2005 | CA2553887A1 Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 08/18/2005 | CA2553886A1 Combined use of prame inhibitors and hdac inhibitors |
| 08/18/2005 | CA2553884A1 Nutritional composition for improving skin condition and preventing skin diseases |
| 08/18/2005 | CA2553724A1 Aminobenzoxazoles as therapeutic agents |
| 08/18/2005 | CA2553658A1 Microemulsion formulations comprising particular substance p antagonists |
| 08/18/2005 | CA2553604A1 New pyridin-2-one compounds useful as inhibitors of thrombin |
| 08/18/2005 | CA2553243A1 Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 08/18/2005 | CA2553039A1 Antiparasitic composition |
| 08/18/2005 | CA2553038A1 Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 08/18/2005 | CA2553033A1 Methods for treatment of complications of diabetes |
| 08/18/2005 | CA2552954A1 Use of an extract of pueraria tuberosa for the treatment of diabetes type 2 |
| 08/18/2005 | CA2552942A1 New compounds, methods for their preparation and use thereof |
| 08/18/2005 | CA2552940A1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 08/18/2005 | CA2552938A1 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
| 08/18/2005 | CA2552937A1 Combination of (a) a dna topoisomerase inhibitor and (b) an iap inhibitor |
| 08/18/2005 | CA2552931A1 Method for producing dry powders of one or several carotenoids |
| 08/18/2005 | CA2552928A1 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 08/18/2005 | CA2552463A1 New compositions containing quinoline compounds |
| 08/18/2005 | CA2552458A1 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 08/18/2005 | CA2552404A1 Methods and compositions for the treatment of lipodystrophy |
| 08/18/2005 | CA2551780A1 The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
| 08/18/2005 | CA2551566A1 Diurea derivatives |
| 08/18/2005 | CA2550848A1 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 08/18/2005 | CA2549083A1 Anti-viral pharmaceutical compositions |
| 08/18/2005 | CA2548210A1 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods |
| 08/18/2005 | CA2536096A1 Compositions and methods for treating contracture |
| 08/18/2005 | CA2519329A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof |
| 08/18/2005 | CA2497216A1 Local vascular delivery of cladribine in combination with rapamycin to prevent restenosis following vascular injury |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1564292A1 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 08/17/2005 | EP1564278A1 Composition containing organic substance having double bond with improved oxidation stability |
| 08/17/2005 | EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation |
| 08/17/2005 | EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 08/17/2005 | EP1564209A1 Process for the preparation of 13-cis-retinoic acid |
| 08/17/2005 | EP1564202A1 Novel process for synthesizing and a novel crystal form of agomelatin as well as pharmaceutical preparations containing these |
| 08/17/2005 | EP1563858A1 Peritoneal dialysis method |
| 08/17/2005 | EP1563850A2 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 08/17/2005 | EP1563848A1 New combinations of an anti-emetic agent and an enkephalinase inhibitor |
| 08/17/2005 | EP1563846A1 Endogenous repair factor production promoters |
| 08/17/2005 | EP1563845A1 Remedies for allergic diseases |
| 08/17/2005 | EP1563841A1 Remedies |
| 08/17/2005 | EP1563840A1 Dengue virus infection inhibitor |
| 08/17/2005 | EP1563839A1 A method of analgesia |
| 08/17/2005 | EP1563838A2 Irrigation solution and method for inhibition of pain and inflammation |
| 08/17/2005 | EP1563837A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent |
| 08/17/2005 | EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 08/17/2005 | EP1563835A1 Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
| 08/17/2005 | EP1563833A1 Pharmaceutical compositions with amorphous tibolone. |
| 08/17/2005 | EP1563832A1 Liposome comprising a compound containing 2 polyalkylene glycol groups |
| 08/17/2005 | EP1563300A2 Diagnostic method for celiac sprue |
| 08/17/2005 | EP1563099A1 Induction of the mitochondrial permeability transition |
| 08/17/2005 | EP1563092A2 Assays and methods based on microcompetition with a foreign polynucleotide |
| 08/17/2005 | EP1563063A2 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 08/17/2005 | EP1562975A2 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| 08/17/2005 | EP1562956A2 Fused bicyclic nitrogen-containing heterocycles |
| 08/17/2005 | EP1562955A1 Quinazoline derivatives as src tyrosine kinase inhibitors |
| 08/17/2005 | EP1562946A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs |
| 08/17/2005 | EP1562945A1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof |
| 08/17/2005 | EP1562944A1 Pyrazoloquinolines with immunomodulating activity |
| 08/17/2005 | EP1562943A1 Fused heterocyclic compounds |
| 08/17/2005 | EP1562940A2 Aryl sulfonamides |
| 08/17/2005 | EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 08/17/2005 | EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562932A1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 08/17/2005 | EP1562930A2 Synthetic lactone formulations and method of use |
| 08/17/2005 | EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/17/2005 | EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 08/17/2005 | EP1562922A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 08/17/2005 | EP1562914A1 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
| 08/17/2005 | EP1562912A2 Process for preparation of rosuvastatin calcium |
| 08/17/2005 | EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases |
| 08/17/2005 | EP1562909A1 Ophthalmic compositions for treating ocular hypertension |
| 08/17/2005 | EP1562906A2 Heterocyclic selective androgen receptor modulators and methods of use thereof |
| 08/17/2005 | EP1562903A2 Mucin synthesis inhibitors |
| 08/17/2005 | EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 08/17/2005 | EP1562901A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/17/2005 | EP1562900A1 Polymorphs of bicifadine hydrochloride |
| 08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/17/2005 | EP1562892A1 Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments |
| 08/17/2005 | EP1562633A1 Pharmaceutical product for endonasal administration for treating central nervous system diseases and disorders |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562627A2 Corticosteroid conjugates and uses thereof |
| 08/17/2005 | EP1562624A2 Orally administered peptides synergize statin activity |
| 08/17/2005 | EP1562620A2 Modified cytokines for use in cancer therapy |